Warfarin and Pharmacogenomic Testing: What Would Pascal Do?

被引：4
|
作者：
Teagarden, J. Russell [1 ]
机构：
[1] Medco Hlth Solut Inc, Franklin Lakes, NJ 07417 USA
来源：
PHARMACOTHERAPY | 2009年 / 29卷 / 03期
关键词：
evidence-based medicine; anticoagulation; pharmacogenomics; patient safety; warfarin; ANTICOAGULATION; CYP2C9;
D O I：
10.1592/phco.29.3.245
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [1] Pharmacogenomic Testing and Warfarin Management
    Maluso, Andrea
    [J]. ONCOLOGY NURSING FORUM, 2015, 42 (05) : 563 - 565
  • [2] Pharmacogenomic testing and response to warfarin
    Wu, Alan H. B.
    [J]. LANCET, 2015, 385 (9984): : 2231 - 2232
  • [3] Warfarin pharmacogenomic testing platforms
    Wu, Alan H. B.
    [J]. PHARMACOGENOMICS, 2008, 9 (08) : 1002 - 1003
  • [4] At what age would pharmacogenomic testing be most useful in the general population?
    Kimpton, J. E.
    Robinson, A.
    Threapleton, C. J.
    Cook, D.
    Harris, T.
    Baker, E. H.
    Carey, I.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1639 - 1640
  • [5] Pharmacogenomic Testing and Warfarin What Evidence Has the GIFT Trial Provided?
    Emery, Jon D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (12): : 1110 - 1112
  • [6] Warfarin and pharmacogenomic testing: The case for restraint
    Garcia, D. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 303 - 305
  • [7] WHAT WOULD I DO FOR YOU, WHAT WOULD YOU DO FOR ME?
    Binder, Emma
    [J]. MICHIGAN QUARTERLY REVIEW, 2024, 64 (01) : 128 - 142
  • [8] What Would I Do?
    崔莹萍
    [J]. 中学生英语, 2002, (03) : 22 - 22
  • [9] What Would Nabokov Do?
    Prener, Nan
    [J]. NEW YORK TIMES BOOK REVIEW, 2014, 119 (08): : 6 - 6
  • [10] What Would Agrippina Do?
    Boatwright, Mary T.
    [J]. TRANSACTIONS OF THE AMERICAN PHILOLOGICAL ASSOCIATION, 2020, 150 (02): : 253 - 261
12345